Live feed02:30:00·4mPRReleasevia QuantisnowEnhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid TumorsByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
